[1] Leclerc H. Biochemical study of pigmented Enterobacteriaceae. Ann Inst Pasteur (Paris), 1962; 102, 726−41.
[2] Keren Y, Keshet D, Eidelman M, et al. Is Leclercia adecarboxylata a new and unfamiliar marine pathogen?. J Clin Microbiol, 2014; 52, 1775−6. doi:  10.1128/JCM.03239-13
[3] Grantham WJ, Funk SS, Schoenecker JG. Leclercia adecarboxylata musculoskeletal infection in an immune competent pediatric patient: An emerging pathogen?. Case Rep Orthop, 2015; 2015, 160473.
[4] Keyes J, Johnson EP, Epelman M, et al. Leclercia adecarboxylata: An emerging pathogen among pediatric infections. Cureus, 2020; 12, e8049.
[5] Hurley EH, Cohen E, Katarincic JA, et al. Leclercia adecarboxylata infection in an immunocompetent child. R I Med J (2013), 2015; 98, 41−4.
[6] Haji SH, Aka STH, Ali FA. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS One, 2021; 16, e0259005. doi:  10.1371/journal.pone.0259005
[7] Awoke T, Teka B, Aseffa A, et al. Detection of bla KPC and bla NDM carbapenemase genes among Klebsiella pneumoniae isolates in Addis Ababa, Ethiopia: Dominance of bla NDM . PLoS One, 2022; 17, e0267657. doi:  10.1371/journal.pone.0267657
[8] Shin GW, You MJ, Lee HS, et al. Catheter-related bacteremia caused by multidrug-resistant Leclercia adecarboxylata in a patient with breast cancer. J Clin Microbiol, 2012; 50, 3129−32. doi:  10.1128/JCM.00948-12
[9] Garza-González E, Bocanegra-Ibarias P, Rodríguez-Noriega E, et al. Molecular investigation of an outbreak associated with total parenteral nutrition contaminated with NDM-producing Leclercia adecarboxylata. BMC Infect Dis, 2021; 21, 235. doi:  10.1186/s12879-021-05923-0
[10] Alosaimi RS, Muhmmed Kaaki M. Catheter-related ESBL-producing Leclercia adecarboxylata septicemia in hemodialysis patient: An emerging pathogen?. Case Rep Infect Dis, 2020; 2020, 7403152.
[11] Spiegelhauer MR, Andersen PF, Frandsen TH, et al. Leclercia adecarboxylata: a case report and literature review of 74 cases demonstrating its pathogenicity in immunocompromised patients. Infect Dis (Lond), 2019; 51, 179−88. doi:  10.1080/23744235.2018.1536830
[12] Broderick A, Lowe E, Xiao A, et al. Leclercia adecarboxylata folliculitis in a healthy swimmer-An emerging aquatic pathogen?. JAAD Case Rep, 2019; 5, 706−8. doi:  10.1016/j.jdcr.2019.06.007
[13] Adapa S, Konala VM, Javed T, et al. Peritonitis from Leclercia adecarboxylata: An emerging pathogen. Clin Case Rep, 2019; 7, 829−31. doi:  10.1002/ccr3.2094
[14] Sun Q L, Wang HY, Shu LB, et al. Leclercia adecarboxylata from human gut flora carries mcr-4.3 and bla IMP-4 -bearing plasmids. Front Microbiol, 2019; 10, 2805. doi:  10.3389/fmicb.2019.02805
[15] Hassan I, Gupta P, Ray P, et al. Leclercia adecarboxylata causing spontaneous bacterial peritonitis in a child with nephrotic syndrome: A case report and review of literature. J Lab Physicians, 2020; 12, 222−4. doi:  10.1055/s-0040-1721162
[16] Lévesque S, Dufresne PJ, Soualhine H, et al. A side by side comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory. PLoS One, 2015; 10, e0144878. doi:  10.1371/journal.pone.0144878
[17] Gajic I, Kabic J, Kekic D, et al. Antimicrobial susceptibility testing: A comprehensive review of currently used methods. Antibiotics (Basel), 2022; 11, 427 . doi:  10.3390/antibiotics11040427
[18] Li RC, Xie MM, Dong N, et al. Efficient generation of complete sequences of MDR-encoding plasmids by rapid assembly of MinION barcoding sequencing data. GigaScience, 2018; 7, 1−9.
[19] Aarab A, Saddari A, Noussaiba B, et al. Leclercia adecarboxylata invasive infection in a patient with Hirschsprung disease: A case report. Ann Med Surg (Lond), 2021; 71, 102927. doi:  10.1016/j.amsu.2021.102927